The health and human services secretary is shrinking staff at health agencies and reshaping the mission of his department to ...

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly reduced” breast tissue cell growth, which is a major indicator of cancer ...

A revolutionary immunotherapy has stunned doctors by making an aggressive, previously incurable blood cancer vanish in some ...

What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC ...

Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...

The study adds to growing evidence that digital tools can maximize genetic counselors' limited time without patient harm.

Art Bra Austin aims to pay tribute to breast cancer survivors while raising funds for the Breast Cancer Resource Center (BCRC), a Central Texas nonprofit that provides free, personalized services ...

New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

On June 4, analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Immix Biopharma, Inc. (NASDAQ:IMMX) with a ...

PARP inhibitors demonstrate synergy with radiation, so investigators tested the efficacy and safety of olaparib plus radium-223 in patients with mCRPC and bone metastases in a phase 2 trial.